Abstract
There is a gradual increase in the brain 5-hydroxytryptamine (5-HT) turnover rate over a three-day period after morphine pellet implantation in mice. p-Chlorophenylalanine (PCPA) given in conjunction with morphine injections partially suppresses not only the development of tolerance to morphine but also cross-tolerance development to several narcotic and narcotic antagonist analgesics. When the same mice are tested for physical dependence by the naloxone-induced jumping syndrome, PCPA fails to alter the incidence of jumping. In morphine-implanted mice, pargyline pretreatment before the naloxone challenge, greatly enhances the jumping syndrome. PCPA or reserpine given before and during morphine implantation does not decrease the incidence of naloxone-induced jumping. The brain 5-HT turnover between mice that jumped and the nonjumping mice does not differ. There appears to be no causal relation between brain 5-HT metabolism and physical dependence but some relation between tolerance and 5-HT turnover may exist.
Footnotes
- Received November 16, 1970.
- Accepted February 22, 1971.
- © 1971, by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
